THE COSTS OF INTRODUCING A MALARIA VACCINE THROUGH THE EXPANDED PROGRAM ON IMMUNIZATION IN TANZANIA
- 1 August 2006
- journal article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 75 (2_suppl) , 119-130
- https://doi.org/10.4269/ajtmh.2006.75.119
Abstract
This report presents an approach to costing the delivery of a malaria vaccine through the expanded program on immunization (EPI), and presents the predicted cost per dose delivered and cost per fully immunized child (FIC) in Tanzania, which are key inputs to the cost-effectiveness analysis. The costs included in the analysis are those related to the purchase of the vaccine taking into account the wastage rate; the costs of distributing and storing the vaccine at central, zonal, district, and facility level; those of managing the vaccination program; the costs of delivery at facility level (including personnel, syringes, safety boxes, and waste management); and those of additional training of EPI personnel and of social mobilization activities. The average cost per FIC increases almost linearly from US$4.2 per FIC at a vaccine price of US$1 per dose to US$31.2 at vaccine price of US$10 per dose. The marginal cost is approximately 5% less than the average cost. Although the vaccine price still determines most of the total delivery costs, the analysis shows that other costs are relevant and should be taken into account before marketing the vaccine and planning its inclusion into the EPI.Keywords
This publication has 16 references indexed in Scilit:
- PREDICTING THE COST-EFFECTIVENESS OF INTRODUCING A PRE-ERYTHROCYTIC MALARIA VACCINE INTO THE EXPANDED PROGRAM ON IMMUNIZATION IN TANZANIAThe American Journal of Tropical Medicine and Hygiene, 2006
- Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: a theoretical modeling analysisVaccine, 2001
- Guidelines for authors and peer reviewers of economic submissions to the BMJBMJ, 1996
- Immunization programs and their costsSocial Science & Medicine, 1994
- Standardizing economic appraisal of health technology in the European communitySocial Science & Medicine, 1994
- Should Yellow Fever Vaccine be Included in the Expanded Program of Immunization in Africa? A Cost-Effectiveness Analysis for NigeriaThe American Journal of Tropical Medicine and Hygiene, 1993
- Standardizing Methodologies for Economic Evaluation in Health Care: Practice, Problems, and PotentialInternational Journal of Technology Assessment in Health Care, 1993
- Cost-Effectiveness and Cost-Benefit Analyses in the Medical LiteratureAnnals of Internal Medicine, 1992
- Estimating vaccine costs for epi cost-effectiveness analysisThe International Journal of Health Planning and Management, 1990
- Estimating Costs in the Economic Evaluation of Medical TechnologiesInternational Journal of Technology Assessment in Health Care, 1990